BMRN vs PDFS · P/E 40, rev $1.76B vs P/E 339, rev $121.7M
Biomarin Pharmaceutical Inc (BMRN) versus PDF Solutions Inc (PDFS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
PDF Solutions Inc (PDFS) is a software - application company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PDFS revenue for 2026-06-30 was $121.7M. Net income was $9.1M. PDFS currently screens at market cap $2.56B and trailing P/E 339.3.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PDFS currently screens at market cap $2.56B and trailing P/E 339.3.
Not investment advice. Open the BMRN and PDFS stock pages for the full models.
Not investment advice.